441 related articles for article (PubMed ID: 26230271)
1. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
[TBL] [Abstract][Full Text] [Related]
2. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
[TBL] [Abstract][Full Text] [Related]
4. Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs.
Singh T; Taitel M; Loy D; Smith-Ray R
J Manag Care Spec Pharm; 2020 Jan; 26(1):42-47. PubMed ID: 31880234
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
6. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
[TBL] [Abstract][Full Text] [Related]
8. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
[TBL] [Abstract][Full Text] [Related]
9. What If the Influenza Vaccine Did Not Offer Such Variable Protection?
Bartsch SM; Mitgang EA; Geller G; Cox SN; O'Shea KJ; Boyce A; Siegmund SS; Kahn J; Lee BY
J Infect Dis; 2020 Sep; 222(7):1138-1144. PubMed ID: 32386323
[TBL] [Abstract][Full Text] [Related]
10. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
[TBL] [Abstract][Full Text] [Related]
11. The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population.
Young-Xu Y; van Aalst R; Russo E; Lee JK; Chit A
PLoS One; 2017; 12(1):e0169344. PubMed ID: 28046080
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
[TBL] [Abstract][Full Text] [Related]
13. Future epidemiological and economic impacts of universal influenza vaccines.
Sah P; Alfaro-Murillo JA; Fitzpatrick MC; Neuzil KM; Meyers LA; Singer BH; Galvani AP
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20786-20792. PubMed ID: 31548402
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness analysis of elementary school-located vaccination against influenza--results from a randomized controlled trial.
Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
Vaccine; 2013 Apr; 31(17):2156-64. PubMed ID: 23499607
[TBL] [Abstract][Full Text] [Related]
15. Economic burden of seasonal influenza in the United States.
Putri WCWS; Muscatello DJ; Stockwell MS; Newall AT
Vaccine; 2018 Jun; 36(27):3960-3966. PubMed ID: 29801998
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
17. Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage.
Karve S; Meier G; Davis KL; Misurski DA; Wang CC
Vaccine; 2013 Jul; 31(33):3370-88. PubMed ID: 23707697
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
Xu J; Zhou F; Reed C; Chaves SS; Messonnier M; Kim IK
Vaccine; 2016 Jun; 34(27):3149-3155. PubMed ID: 27161997
[TBL] [Abstract][Full Text] [Related]
19. Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.
Foppa IM; Cheng PY; Reynolds SB; Shay DK; Carias C; Bresee JS; Kim IK; Gambhir M; Fry AM
Vaccine; 2015 Jun; 33(26):3003-9. PubMed ID: 25812842
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.
Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M
BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
